SCHEMBL773601

SCHEMBL773601

CCOC(=O)c1cnn(CC(C)C)c1-c1ccncc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
CDC7 O00311 6/20 0.47
DBF4 Q9UBU7 5/20 0.47
CASP1 P29466 1/20 0.44
MAPK1 P28482 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
NPC1 O15118 1/20 0.44
LMNA P02545 1/20 0.44
CSNK1D P48730 1/20 0.43
PDE4B Q07343 1/20 0.43
HPGD P15428 2/20 0.42
CLK1 P49759 1/20 0.42
UBE2N P61088 1/20 0.42
HSD17B10 Q99714 1/20 0.42
KMT2A Q03164 2/20 0.41
ROCK2 O75116 1/20 0.41
PIM1 P11309 1/20 0.41
GSK3B P49841 1/20 0.41
HIPK2 Q9H2X6 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL772322 0.83 ALDH1A1 (0.50) ALDH1A1CDC7DBF4CASP1MAPK1
SCHEMBL771673 0.81 LMNA (0.57) ALDH1A1CDC7DBF4CASP1MAPK1
SCHEMBL772745 0.79 ALDH1A1 (0.55) ALDH1A1CDC7DBF4MAPK1NPSR1
SCHEMBL6154283 0.79 KMT2A (0.53) ALDH1A1NPC1LMNAPDE4BHPGD
SCHEMBL15750636 0.79 ALDH1A1 (0.53) ALDH1A1CDC7DBF4CASP1MAPK1
SCHEMBL31352277 0.77 NPC1 (0.62) ALDH1A1NPC1LMNAHPGDHSD17B10
SCHEMBL11230793 0.75 CASP1 (0.53) ALDH1A1CDC7DBF4CASP1MAPK1
SCHEMBL2088511 0.73 KDM4E (0.47) ALDH1A1CASP1NPC1LMNAPDE4B
SCHEMBL774907 0.73 LMNA (0.47) ALDH1A1CDC7DBF4CASP1MAPK1
SCHEMBL3491679 0.72 ALDH1A1 (0.65) ALDH1A1MAPK1NPC1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440554-B1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO SA (CH) 2016-10-05 EP disclosed
US-8802663-B2 Pyrazole oxadiazole derivatives as S1P1 agonists MERCK SERONO SA (CH) 2014-08-12 US disclosed
US-8802663-B2 Pyrazole oxadiazole derivatives as S1P1 agonists MERCK SERONO SA (CH) 2014-08-12 US disclosed
US-8802663-B2 Pyrazole oxadiazole derivatives as S1P1 agonists MERCK SERONO SA (CH) 2014-08-12 US disclosed
EP-2440554-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS Merck Serono S.A. (CH) 2012-04-18 EP disclosed
US-20120071460-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO SA (CH) 2012-03-22 US disclosed
US-20120071460-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO SA (CH) 2012-03-22 US disclosed
US-20120071460-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO SA (CH) 2012-03-22 US disclosed
WO-2010142628-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO S.A. (CH) 2010-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071460-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS S1PR1, S1PR3, S1PR2 ALDH1A1 1615/4885CDC7 2912/4885DBF4 3616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.